Tadalafil/Dutasteride (Yuyu Pharma)

N/A

Report date: 2025/12/03 10:09:56
NME

Base Information

Drug NameTadalafil/Dutasteride (Yuyu Pharma)
Drug Alias NameYY-201(Yuyu Pharma)YY201(Yuyu Pharma)
ClassificationSmall molecules > Steroids
Mechanisms of ActionSteroid 5 alpha reductase inhibitorsPhosphodiesterase 5A inhibitors
TargetsSteroid 5 alpha reductasePhosphodiesterase 5A
Therapy Area/IndicationsProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesYuyu Pharma. Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYuyu Pharma. Inc
Active IndicationsN/A
Inactive IndicationsProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksN/A